Drug research

PLN-74809

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Evaluation of Efficacy and Safety of PLN-74809 in Patients With Idiopathic Pulmonary FibrosisNCT04396756	PLRX	Phase 2	Completed	2023-02-01Actual
Imaging Evaluation of PLN-74809 in Participants With IPF (PLN-74809)NCT05621252	PLRX	Phase 2	Completed	2023-12-27Actual
Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC)NCT04480840	PLRX	Phase 2	Completed	2024-02-26Actual
Phase 2a Evaluation of PLN-74809 on αvβ6 Receptor Occupancy Using PET Imaging in Participants With IPF/NCT04072315	PLRX	Phase 2	Completed	2022-06-27Actual
Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary FibrosisNCT06097260	PLRX	Phase 2	Terminated	2025-04-04Actual

PLRXCompletedPrimary completion: 2023-02-01 · Actual

Trial details

PLRXCompletedPrimary completion: 2023-12-27 · Actual

Trial details

PLRXCompletedPrimary completion: 2024-02-26 · Actual

Trial details

PLRXCompletedPrimary completion: 2022-06-27 · Actual

Trial details

PLRXTerminatedPrimary completion: 2025-04-04 · Actual

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.